Observation of Blood Lipid Outcomes in Lipid Clinic
1 other identifier
observational
500
1 country
1
Brief Summary
Taipei MacKay Memorial Hospital will establish a Lipid Clinic for hyperlipidemic patients. In this Lipid Clinic, the physician will discuss with each individual patient and set an individualized LDL goal according to current guideline and regulation of National Health Insurance Administration (NHIA). The aim of this study is to observe blood lipid outcomes in patients who receive treatment in Lipid Clinic of Taipei MacKay Memorial Hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 26, 2019
CompletedStudy Start
First participant enrolled
January 3, 2020
CompletedFirst Posted
Study publicly available on registry
January 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJanuary 7, 2020
January 1, 2020
12 months
December 26, 2019
January 3, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Lipid profile
check serum level of LDL-C
12 month
Study Arms (1)
Dyslipidemic patients
Patients who meet the criteria of high-risk category according to 2017 Taiwan Lipid Guideline for High-Risk Patients have a abnormal serum LDL-C level
Interventions
Physicians educate patients and provide a clear information about optimal LDL-C value according to individual patient's condition according to current guidelines
Eligibility Criteria
Patients who are ≥20 years, have abnormal lipid profiles, need lipid-lowering drugs according to 2017 Taiwan Lipid Guideline in Lipid Clinic of Taipei MacKay Memorial Hospital.
You may qualify if:
- ≥20 years-old
- Abnormal lipid profiles according to 2017 Taiwan Lipid Guideline for High-risk Patients
You may not qualify if:
- Reject to participate in this study
- Pregnant women
- Prisoner
- Illiteracy
- HIV patients
- Individuals who are mentally retarded, homeless, and handicapped
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mackay Memorial Hospitallead
- Amgencollaborator
Study Sites (1)
Taiwan, Taipei, Mackay Memorial hospital
Taipei, 104, Taiwan
Related Publications (1)
Li YH, Ueng KC, Jeng JS, Charng MJ, Lin TH, Chien KL, Wang CY, Chao TH, Liu PY, Su CH, Chien SC, Liou CW, Tang SC, Lee CC, Yu TY, Chen JW, Wu CC, Yeh HI; Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients. 2017 Taiwan lipid guidelines for high risk patients. J Formos Med Assoc. 2017 Apr;116(4):217-248. doi: 10.1016/j.jfma.2016.11.013. Epub 2017 Feb 24.
PMID: 28242176BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chao-Feng Lin, PhD
Mackay Memorial Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 26, 2019
First Posted
January 7, 2020
Study Start
January 3, 2020
Primary Completion
December 31, 2020
Study Completion
December 31, 2025
Last Updated
January 7, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share
We will not provide IPD to other researchers according to IRB regulation.